SAALI Biotechnologies Aps: Financial statements 2022
CVR: 38619292
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
SAALI Biotechnologies Aps (CVR 38619292) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK -1,896 compared with DKK -44,357 the year before. Equity in the 2022 report amounted to DKK -10,525.
- Profit/Loss
- DKK -1,896
- Equity
- DKK -10,525
- Total Assets
- DKK 0
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | - | -2K | -11K | 0 |
| 2021 | 0 | 0 | -44K | -10K | 0 |
| 2020 | 0 | 0 | 0 | -10K | 0 |
| 2019 | - | -4K | -44K | -10K | - |
| 2018 | - | -6K | 5K | 35K | - |
Official annual report
Keep an eye on SAALI Biotechnologies Aps
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
SAALI Biotechnologies Aps has published its annual report for 2021. Revenue came to DKK 0, and the net result was DKK -44,357.
About SAALI Biotechnologies Aps
SAALI Biotechnologies Aps is a Danish company of the type Anpartsselskab based in Skanderborg, founded in 2017. The company is registered under the industry Anden forarbejdning og konservering af frugt og grøntsager. The management consists of Sander Sieuwerts and Lina Nadirova. The company is owned by Sander Sieuwerts and Lina Nadirova. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -1,348 compared with DKK -1,237 the year before. Equity in the 2025 report amounted to DKK -13,201.